Research output per year
Research output per year
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Antagonizing FcαR1 (CD89) as treatment in IgA-mediated chronic inflammation and autoimmunity
van Delft, M. A. M., Aleyd, E., Mast, R. V. D., de Jong, N., Boon, L., Simons, P. J. & van Egmond, M., 2023, In: Frontiers in immunology. 14, p. 1118539 1118539.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
IgA blocking FcαR1 (CD89) antibodies to treat IgA-mediated tissue damage in chronic inflammation and autoimmunity
van Delft - Soffers, M. A. M., Aleyd, E., van der Mast, R., van Egmond, M., Boon, L. & Simons, P. J., 2023.Research output: Contribution to conference › Abstract › Academic
-
In rheumatoid arthritis, IgA autoantibodies are present in a polymeric state; clues for a mucosal origin of the autoimmune response?
van Delft - Soffers, M. A. M., van Mourik, A., Toes, R. E. M., van der Woude, D., Trouw, L. A. & van Schie, K., 2023.Research output: Contribution to conference › Abstract › Academic
-
Blocking FcαR1 (CD89)/IgA interaction using CD89 specific antibodies is a potential therapeutic target to resolve tissue damage in chronic inflammation and autoimmunity
van Delft - Soffers, M. A. M., Aleyd, E., van Egmond, M., van der Mast, R., Boon, L. & Simons, P. J., 2022.Research output: Contribution to conference › Abstract › Academic
-
Anti-carbamylated protein antibodies: are they useful for the diagnosis of rheumatoid arthritis?
Ponchel, F., van Delft, M., Emery, P., Trouw, L. & Burska, A. N., Jan 2021, In: Clinical and experimental rheumatology. 39, p. A14-A14Research output: Contribution to journal › Meeting Abstract › Academic
Prizes
-
best abstract in "inflammatory diseases"
van Delft - Soffers, Myrthe (Recipient), 2022
Prize › Academic